Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18387850 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Genetic: CERE-120: AAV2-NTN

Study has passed its completion date and status has not been verified in more than two years.